104 related articles for article (PubMed ID: 12839032)
21. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of injury in uromodulin-associated kidney disease.
Kumar S
J Am Soc Nephrol; 2007 Jan; 18(1):10-2. PubMed ID: 17182881
[No Abstract] [Full Text] [Related]
23. Identification of a new locus for medullary cystic disease, on chromosome 16p12.
Scolari F; Puzzer D; Amoroso A; Caridi G; Ghiggeri GM; Maiorca R; Aridon P; De Fusco M; Ballabio A; Casari G
Am J Hum Genet; 1999 Jun; 64(6):1655-60. PubMed ID: 10330352
[TBL] [Abstract][Full Text] [Related]
24. [A newborn infant with an adult-type kidney disease].
Visser G; Cobben JM; Troelstra JA; van Lingen RA
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):289-91. PubMed ID: 1741072
[TBL] [Abstract][Full Text] [Related]
25. [Autosomal dominant polycystic kidney disease: from genes to cilium].
Magistroni R; Furci L; Albertazzi A
G Ital Nefrol; 2008; 25(2):183-91. PubMed ID: 18350498
[TBL] [Abstract][Full Text] [Related]
26. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
[TBL] [Abstract][Full Text] [Related]
27. [Polycystic kidney diseases: molecular genetics and counselling].
Lespinasse J; Fourcade J; Schir F
Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
[TBL] [Abstract][Full Text] [Related]
28. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
Sweeney WE; Avner ED
Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
[TBL] [Abstract][Full Text] [Related]
29. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
[TBL] [Abstract][Full Text] [Related]
30. [Familial juvenile hyperuricemic nephropathy (FJHN)].
Kudo E; Itakura M
Nihon Rinsho; 2008 Apr; 66(4):683-6. PubMed ID: 18409515
[TBL] [Abstract][Full Text] [Related]
31. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
[TBL] [Abstract][Full Text] [Related]
32. PKDB: Polycystic Kidney Disease Mutation Database--a gene variant database for autosomal dominant polycystic kidney disease.
Gout AM; Martin NC; Brown AF; Ravine D
Hum Mutat; 2007 Jul; 28(7):654-9. PubMed ID: 17370309
[TBL] [Abstract][Full Text] [Related]
33. [Cystic kidney surveyed genetically--a new chromosome 4 locus].
Nørby S
Ugeskr Laeger; 1994 Jan; 156(5):661-2. PubMed ID: 8184502
[No Abstract] [Full Text] [Related]
34. Toward the identification of a gene for familial juvenile nephronophthisis (autosomal recessive medullary cystic kidney disease).
Antignac C; Kleinknecht C; Habib R
Adv Nephrol Necker Hosp; 1995; 24():379-93. PubMed ID: 7572421
[No Abstract] [Full Text] [Related]
35. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
[TBL] [Abstract][Full Text] [Related]
36. Gene time for polycystic kidney disease.
Avner ED
Lancet; 1994 Sep; 344(8926):833-4. PubMed ID: 7916394
[No Abstract] [Full Text] [Related]
37. Familial nephropathy associated with hyperuricemia in Spain: our experience with 3 families harbouring a UMOD mutation.
Puig JG; Prior C; Martínez-Ara J; Torres RJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1295-300. PubMed ID: 17065110
[TBL] [Abstract][Full Text] [Related]
38. Autosomal dominant polycystic kidney disease: from molecular genetics to the patients.
Grünfeld JP; Chauveau D; Knebelmann B
Clin Investig; 1992 Sep; 70(9):791-3. PubMed ID: 1450633
[TBL] [Abstract][Full Text] [Related]
39. The genetics of cystic diseases of the kidney.
Kimberling WJ; Pieke-Dahl SA; Kumar S
Semin Nephrol; 1991 Nov; 11(6):596-606. PubMed ID: 1767134
[No Abstract] [Full Text] [Related]
40. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
